Covered recipient · General Payments record
TAMMY MELISSA MELISSA SOLOMON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,029.03
- Reported across 138 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $534.56 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $148.86 | 10 |
| ABBVIE INC. | $142.24 | 13 |
| Novo Nordisk AS | $85.37 | 5 |
| Mylan Specialty L.P. | $34.52 | 2 |
| Exact Sciences Corporation | $31.64 | 2 |
| Axsome Therapeutics, Inc. | $26.19 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.95 | 1 |
| Ardelyx, Inc. | $16.12 | 1 |
| PFIZER INC. | $15.94 | 1 |
| ITI, Inc. | $15.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.04 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230479 | CMS |
| ABBVIE INC. | $12.95 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230481 | CMS |
| ABBVIE INC. | $9.32 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230483 | CMS |
| ABBVIE INC. | $14.49 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230485 | CMS |
| ABBVIE INC. | $9.42 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230487 | CMS |
| ABBVIE INC. | $32.74 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230489 | CMS |
| ABBVIE INC. | $11.26 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230491 | CMS |
| ABBVIE INC. | $10.21 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230493 | CMS |
| ABBVIE INC. | $6.34 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230495 | CMS |
| ABBVIE INC. | $3.21 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230497 | CMS |
| ABBVIE INC. | $7.52 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230499 | CMS |
| ABBVIE INC. | $7.48 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230501 | CMS |
| ABBVIE INC. | $1.26 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108230503 | CMS |
| Ardelyx, Inc. | $16.12 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146746377 | CMS |
| Axsome Therapeutics, Inc. | $26.19 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148413866 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.95 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086314115 | CMS |
| Exact Sciences Corporation | $15.82 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114910261 | CMS |
| Exact Sciences Corporation | $15.82 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114910276 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.73 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143607612 | CMS |
| Lilly USA, LLC | $17.62 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135962493 | CMS |
| Lilly USA, LLC | $15.02 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135870516 | CMS |
| Lilly USA, LLC | $15.49 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920486 | CMS |
| Lilly USA, LLC | $21.46 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959603 | CMS |
| Lilly USA, LLC | $14.30 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959227 | CMS |
| Lilly USA, LLC | $23.44 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920488 | CMS |
| Lilly USA, LLC | $12.80 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135952526 | CMS |
| Lilly USA, LLC | $16.47 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920490 | CMS |
| Lilly USA, LLC | $11.69 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135894277 | CMS |
| Lilly USA, LLC | $0.57 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959229 | CMS |
| Mylan Specialty L.P. | $15.76 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147287152 | CMS |
| Mylan Specialty L.P. | $18.76 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147332409 | CMS |
| Novo Nordisk Inc | $14.93 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100542878 | CMS |
| Novo Nordisk Inc | $17.23 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100483427 | CMS |
| Novo Nordisk Inc | $17.23 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100370107 | CMS |
| Novo Nordisk Inc | $21.56 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100547134 | CMS |
| Novo Nordisk Inc | $14.42 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100408169 | CMS |
| PFIZER INC. | $15.94 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131907261 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.